Text Size
Santen Global

2003 Press Release

RSS

Press Release

Santen Reorganizes Domestic Sales Operation [PDF:14KB]
Santen Signs Agreement With Johnson & Johnson Vision Care, Inc. To Supply Prescription Ophthalmic Products [PDF:18KB]
Santen Announces Financial Results for the First Six Months ended September 30, 2003 [PDF:15KB]
Santen Establishes the SAIN Sales Force Automation System [PDF:73KB]
Santen Announces Closure of its U.S. Subsidiary, Phacor Inc. [PDF:15KB]
Santen Files for Manufacturing Approval for its Vernal Keratoconjunctivitis Treatment, Ciclosporin Ophthalmic Solution [PDF:19KB]
Santen Announces Financial Results for the First Quarter of Fiscal Year 2003 (Three Months Ended June 30, 2003)
Santen Hosts the 91st Annual General Meeting of Shareholders
Notice of the 91st Annual General Meeting of Shareholders [PDF:60KB]
Santen Announces Proposed Change of Accounting Auditors [PDF:15KB]
Santen Announces Financial Results for the Year ended March 31, 2003 [PDF:57KB]
Santen to Issue Stock Acquisition Rights for the Purpose of Granting Stock Options [PDF:22KB]
Santen to Shorten Office Term of Directors and Appoint Outside Director [PDF:14KB]
Notice Regarding Share Buyback [PDF:14KB]
Santen Submits New Drug Application to FDA for Levofloxacin 1.5% Ophthalmic Solution [PDF:15KB]
Santen Files Complaint Against Sante Japan Alleging Unlawful Use of "Sante" Marks [PDF:13KB]
Santen Purchases Own Shares on Market by ToSTNet-2 [PDF:12KB]
Santen to Purchase Own Shares on Market by ToSTNet-2 [PDF:15KB]
Revision of Performance Forecasts[PDF:41KB]
2003-2005 Medium-term Management Plan [PDF:38KB]
News Archive
Copyright © 2023 Santen Pharmaceutical Co., Ltd.
All Rights Reserved